Improving cervical cancer screening and treatment in Mozambique
Official title: A hybrid type III effectiveness-implementation, pragmatic intervention trial for cervical cancer screen and treat in Mozambique
Funded at Tulane University of Louisiana · NIH-11000924 · Data updated 2026-11-12
This study is looking to make cervical cancer screening easier and more comfortable for women in Mozambique by letting them collect their own samples for HPV testing, so they can get the care they need more easily.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $643,363 |
| NIH project number | 1U01CA294674-01 |
| Project ID | NIH-11000924 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women aged 25-49 living in Mozambique who are at risk for cervical cancer.
✕Less likely to help
Patients outside the target age range or those not residing in Mozambique may not benefit from this research.
What this research studies
This research aims to enhance cervical cancer screening and treatment in Mozambique by implementing a hybrid approach that combines effectiveness and implementation strategies. It focuses on using self-sampling for HPV testing, which allows women to collect samples themselves, thereby increasing accessibility and comfort. The study will evaluate the best practices for deploying this Screen & Treat approach, guided by a framework that promotes the integration of evidence-based practices into clinical care. By addressing barriers to screening, the research seeks to improve health outcomes for women at risk of cervical cancer.
Why it matters
Potential benefit: If successful, this research could significantly reduce cervical cancer deaths by improving access to effective screening and treatment options for women in Mozambique.
How similar studies have gone: Preliminary studies in Mozambique have shown that HPV DNA testing and self-collection methods are feasible and preferred by participants, indicating potential for success in this approach.
Where this research is happening
-
Tulane University of Louisiana
New Orleans, United States Active
Researchers
- Principal investigator: Moon, D. Troy — Tulane University of Louisiana
- Study coordinator: Moon, D. Troy
Related research
Other NIH-funded projects on the same topics.
-
Community and digital tools to reduce HPV and cervical cancer burden
A nurse or health team will test a community-based, digital strategy to help girls and young women, especially in rural areas, get HPV vaccination and cervical cancer prevention services.
-
Community and digital tools to reduce HPV and cervical cancer in women with HIV
A community- and digital-technology program aims to help girls and young women, including those with HIV, get more HPV vaccination and cervical cancer prevention services.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.